Australia launches new stem cell research programme
On November 10, Stem Cells Australia, the professional Stem Cell Research team in Australia, has been formally established to implement the "Special Research Initiative in Stem Cell Science" proposed by the Australian Research council (ARC). The research team, led by world-renowned scientist Martin Pera, a former professor at the university of southern California, has received a $21 million federal grant for the first time to focus on research and treatment of multiple sclerosis, diabetes, stroke and heart disease.
The team, led by the university of Melbourne, comprises eight Research Institutes including monash, the university of Queensland, the university of new south wales, the weike-chang Institute, the Walter and Eliza Hall Institute of Medical Research, the Florey Neuroscience Institutes and the federal scientific and industrial Research organisation (CSIRO).
In fact, the research team is continuing national Stem Cell research after the termination of the Australian Stem Cell Centre (ASCC) led by monash university. ASCC is part of the Australian centre of excellence for biological research. Since its launch in 2002, ASCC has received a total of 100 million Australian dollars from the federal government and 11 million Australian dollars from the Victorian government. ASCC ceased operations at the end of June 2011.
Fundamentally change the direction of health care the Australian government fundamentally values and funds stem cell research and fundamentally change the direction of health care, says the federal minister for innovation, industry and research. The creation of stem cell Australia is an expression of the government's intent. In addition to scientific research, this institution also has the function of encouraging the public to participate in the debate on stem cell issues, ethical discussions and making legal recommendations. The team also explains and publicizes the significance and role of stem cell research to the society through its own work.
- June 18, 2019On March 2, 2009, the ministry of health promulgated the "management measures for clinical application of medical technology", which divides medical technology into three types of management. The seco...view
- April 8, 2018Countstar® attended the 27th annual ESACT-UK meeting on the 11-12th January 2017 in Oxford, UK. During the meeting, Countstar® not only brought a convenient solution for cell counting but also...view
- June 18, 2019A new study suggests that acute myelogenous leukemia (AML) contains a rare type of cell with stem cell characteristics called "leukemia stem cells" that can predict clinical outcomes better than norma...view